Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT01034033 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01034033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01034033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Lead sponsor
Stanford University
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2001
Completion date
January 31, 2099
Enrollment
3,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, gynecologic cancers, ovarian cancer, ovarian/peritoneal/fallopian cancer